248 related articles for article (PubMed ID: 31094298)
1. Solid dispersion technology as a strategy to improve the bioavailability of poorly soluble drugs.
Cid AG; Simonazzi A; Palma SD; Bermúdez JM
Ther Deliv; 2019 Jun; 10(6):363-382. PubMed ID: 31094298
[TBL] [Abstract][Full Text] [Related]
2. Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus.
Zi P; Zhang C; Ju C; Su Z; Bao Y; Gao J; Sun J; Lu J; Zhang C
Eur J Pharm Sci; 2019 Jun; 134():233-245. PubMed ID: 31028820
[TBL] [Abstract][Full Text] [Related]
3. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.
Meng F; Gala U; Chauhan H
Drug Dev Ind Pharm; 2015; 41(9):1401-15. PubMed ID: 25853292
[TBL] [Abstract][Full Text] [Related]
4. Potential of solid dispersions to enhance solubility, bioavailability, and therapeutic efficacy of poorly water-soluble drugs: newer formulation techniques, current marketed scenario and patents.
Alshehri S; Imam SS; Hussain A; Altamimi MA; Alruwaili NK; Alotaibi F; Alanazi A; Shakeel F
Drug Deliv; 2020 Nov; 27(1):1625-1643. PubMed ID: 33207947
[TBL] [Abstract][Full Text] [Related]
5. Spray Congealing: An Emerging Technology to Prepare Solid Dispersions with Enhanced Oral Bioavailability of Poorly Water Soluble Drugs.
Bertoni S; Albertini B; Passerini N
Molecules; 2019 Sep; 24(19):. PubMed ID: 31557815
[TBL] [Abstract][Full Text] [Related]
6. Enhanced solubility of piperine using hydrophilic carrier-based potent solid dispersion systems.
Thenmozhi K; Yoo YJ
Drug Dev Ind Pharm; 2017 Sep; 43(9):1501-1509. PubMed ID: 28425323
[TBL] [Abstract][Full Text] [Related]
7. Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan.
Lee JY; Kang WS; Piao J; Yoon IS; Kim DD; Cho HJ
Drug Des Devel Ther; 2015; 9():2745-56. PubMed ID: 26045660
[TBL] [Abstract][Full Text] [Related]
8. Perspectives on Strategies Using Swellable Polymers in Solid Dispersions for Controlled Drug Release.
Tran TTD; Tran PHL
Curr Pharm Des; 2017; 23(11):1639-1648. PubMed ID: 27774901
[TBL] [Abstract][Full Text] [Related]
9. Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions.
Djuris J; Milovanovic S; Medarevic D; Dobricic V; Dapčević A; Ibric S
Int J Pharm; 2019 Jan; 554():190-200. PubMed ID: 30414899
[TBL] [Abstract][Full Text] [Related]
10. Dosage form designs for the controlled drug release of solid dispersions.
Tran PHL; Tran TTD
Int J Pharm; 2020 May; 581():119274. PubMed ID: 32234566
[TBL] [Abstract][Full Text] [Related]
11. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs.
Vo CL; Park C; Lee BJ
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):799-813. PubMed ID: 24056053
[TBL] [Abstract][Full Text] [Related]
12. Development and in vitro evaluation of solid dispersions as strategy to improve albendazole biopharmaceutical behavior.
Simonazzi A; Cid AG; Paredes AJ; Schofs L; Gonzo EE; Palma SD; Bermúdez JM
Ther Deliv; 2018 Sep; 9(9):623-638. PubMed ID: 30189808
[TBL] [Abstract][Full Text] [Related]
13. Improved dissolution behavior of lipophilic drugs by solid dispersions: the production process as starting point for formulation considerations.
Srinarong P; de Waard H; Frijlink HW; Hinrichs WL
Expert Opin Drug Deliv; 2011 Sep; 8(9):1121-40. PubMed ID: 21722000
[TBL] [Abstract][Full Text] [Related]
14. A comparative study on the effects of amphiphilic and hydrophilic polymers on the release profiles of a poorly water-soluble drug.
Irwan AW; Berania JE; Liu X
Pharm Dev Technol; 2016 Mar; 21(2):231-8. PubMed ID: 25496001
[TBL] [Abstract][Full Text] [Related]
15. Recent advances and patents in solid dispersion technology.
Iqbal B; Ali A; Ali J; Baboota S; Gupta S; Dang S; Shadab M; Sahni JK
Recent Pat Drug Deliv Formul; 2011 Sep; 5(3):244-64. PubMed ID: 21834778
[TBL] [Abstract][Full Text] [Related]
16. Characterization and pharmacokinetic study of itraconazole solid dispersions prepared by solvent-controlled precipitation and spray-dry methods.
Sim T; Lim C; Lee JW; Kim DW; Kim Y; Kim M; Choi S; Choi HG; Lee ES; Kim KS; Kang W; Oh KT
J Pharm Pharmacol; 2017 Dec; 69(12):1707-1715. PubMed ID: 28872678
[TBL] [Abstract][Full Text] [Related]
17. Impact of polymer type on bioperformance and physical stability of hot melt extruded formulations of a poorly water soluble drug.
Mitra A; Li L; Marsac P; Marks B; Liu Z; Brown C
Int J Pharm; 2016 May; 505(1-2):107-14. PubMed ID: 27012984
[TBL] [Abstract][Full Text] [Related]
18. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
[TBL] [Abstract][Full Text] [Related]
19. Enhancing the solubility and bioavailability of poorly water-soluble drugs using supercritical antisolvent (SAS) process.
Abuzar SM; Hyun SM; Kim JH; Park HJ; Kim MS; Park JS; Hwang SJ
Int J Pharm; 2018 Mar; 538(1-2):1-13. PubMed ID: 29278733
[TBL] [Abstract][Full Text] [Related]
20. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
